Regenerative Medical Technology Group annual revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
Regenerative Medical Technology Group Revenue Growth & History (RMTG)
Regenerative Medical Technology Group reported $5.1M in revenue for fiscal 2025, an increase of 24.17% from the previous fiscal year.
View full Regenerative Medical Technology Group company overviewRegenerative Medical Technology Group annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.1M | $992,821 | +24.17% |
| 2024 | 2024-12-31 | $4.1M | $1.7M | +70.44% |
| 2023 | 2023-12-31 | $2.4M | $879,730 | +57.49% |
| 2022 | 2022-12-31 | $1.5M | $1.1M | +249.46% |
| 2021 | 2021-12-31 | $437,887 | $382,805 | +694.97% |
| 2020 | 2020-12-31 | $55,082 | $24,979 | +82.98% |
| 2019 | 2019-12-31 | $30,103 | −$20,013 | −39.93% |
| 2018 | 2018-12-31 | $50,116 | $20,875 | +71.39% |
| 2017 | 2017-12-31 | $29,241 | — | — |
Regenerative Medical Technology Group quarterly revenue
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.0M | $3.0M | +309.10% |
| Q1 2026 | 2026-03-31 | $2.6M | $1.3M | +93.45% |
| Q4 2025 | 2025-12-31 | $1.6M | $61,299 | +4.06% |
| Q3 2025 | 2025-09-30 | $1.2M | $194,226 | +19.69% |
| Q2 2025 | 2025-06-30 | $983,318 | $189,989 | +23.95% |
| Q1 2025 | 2025-03-31 | $1.4M | $547,307 | +66.99% |
| Q4 2024 | 2024-12-31 | $1.5M | $895,255 | +145.44% |
| Q3 2024 | 2024-09-30 | $986,308 | $339,480 | +52.48% |
| Q2 2024 | 2024-06-30 | $793,329 | $431,970 | +119.54% |
| Q1 2024 | 2024-03-31 | $817,034 | $30,836 | +3.92% |
| Q4 2023 | 2023-12-31 | $615,568 | $49,312 | +8.71% |
| Q3 2023 | 2023-09-30 | $646,828 | $279,131 | +75.91% |
| Q2 2023 | 2023-06-30 | $361,359 | $63,837 | +21.46% |
| Q1 2023 | 2023-03-31 | $786,198 | $487,450 | +163.16% |
| Q4 2022 | 2022-12-31 | $566,256 | $313,623 | +124.14% |
| Q3 2022 | 2022-09-30 | $367,697 | $202,655 | +122.79% |
| Q2 2022 | 2022-06-30 | $297,522 | $281,753 | +1786.75% |
| Q1 2022 | 2022-03-31 | $298,748 | $294,305 | +6624.02% |
| Q4 2021 | 2021-12-31 | $252,633 | $249,938 | +9274.14% |
| Q3 2021 | 2021-09-30 | $165,042 | $152,762 | +1243.99% |
| Q2 2021 | 2021-06-30 | $15,769 | −$13,018 | −45.22% |
| Q1 2021 | 2021-03-31 | $4,443 | −$6,877 | −60.75% |
| Q4 2020 | 2020-12-31 | $2,695 | −$2,082 | −43.58% |
| Q3 2020 | 2020-09-30 | $12,280 | $6,058 | +97.36% |
| Q2 2020 | 2020-06-30 | $28,787 | $21,599 | +300.49% |
| Q1 2020 | 2020-03-31 | $11,320 | −$596 | −5.00% |
| Q4 2019 | 2019-12-31 | $4,777 | −$7,040 | −59.58% |
| Q3 2019 | 2019-09-30 | $6,222 | −$5,467 | −46.77% |
| Q2 2019 | 2019-06-30 | $7,188 | −$1,724 | −19.34% |
| Q1 2019 | 2019-03-31 | $11,916 | −$5,782 | −32.67% |
| Q4 2018 | 2018-12-31 | $11,817 | — | — |
| Q3 2018 | 2018-09-30 | $11,689 | — | — |
| Q2 2018 | 2018-06-30 | $8,912 | — | — |
| Q1 2018 | 2018-03-31 | $17,698 | — | — |
Regenerative Medical Technology Group revenue growth trends
Over the last five reported fiscal years, revenue grew from $55,082 to $5.1M, a compound annual growth rate of 147.35%. Regenerative Medical Technology Group's latest reported quarter, Q2 2026, generated $4.0M in revenue, an increase of 309.10% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Regenerative Medical Technology Group source filings ↗